Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiotensin Receptor Blockade In Patients After Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR) Trial

NCT07735130 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT07735130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07735130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiotensin Receptor Blockade In Patients After Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR) Trial
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
June 15, 2030
Enrollment
632 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular hypertrophy, severe aortic stenosis, transcatheter aortic valve replacement (tavr)